Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Most Viewed

  • Published in last 1 year
  • In last 2 years
  • In last 3 years
  • All
Please wait a minute...
  • 1.
    Research advances and clinical hotspot trends in rehabilitation nursing for post-stroke dysphagia: a bibliometrics analysis
    Nana Chen, Ying Han, Qingzhi Xu
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 100-108. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.004
    Abstract (902) HTML (18) PDF (5370 KB) (62)

    Objective

    To analyze the current research landscape and evolving trends in rehabilitation care for post-stroke dysphagia through bibliometric methods, aiming to elucidate research progress and future directions in this field.

    Methods

    Using "stroke," "dysphagia," and "nursing" as search terms, literature was retrieved from the Web of Science database.VOSviewer and CiteSpace software were utilized for keyword co-occurrence analysis, co-citation analysis, and visualization to identify research hotspots and frontiers.

    Results

    A total of 316 relevant articles were included, authored by 1458 researchers from 664 institutions across 44 countries, published in 156 journals, and citing 8471 references from 3021 unique journals.The top three countries in terms of publication output were the United States, China, and Australia.Keyword co-occurrence and burst detection analyses revealed research hotspots, including swallowing function assessment, nursing interventions, nutritional support, aspiration prevention, quality of life, and rehabilitation.Co-citation analysis underscored the critical role of formal dysphagia screening in reducing pneumonia risk and indicated that this field remains in a developmental stage, necessitating further research to optimize nursing strategies.

    Conclusion

    Rehabilitation nursing for post-stroke dysphagia is an active research domain, with current focus on dysphagia screening and aspiration prevention.Future studies should prioritize developing personalized care protocols, advancing technology-assisted swallowing function assessments, and optimizing interdisciplinary collaborative models to drive progress in this field.

  • 2.
    Advances in risk factors and clinical prediction models for post-stroke cognitive impairment
    Wenting Li, Cong Gao, Xiaoling Liao
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 81-86. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.001
    Abstract (742) HTML (47) PDF (2620 KB) (108)

    Post-stroke cognitive impairment (PSCI) is a common complication in stroke survivors,significantly reducing their quality of life and impairing long-term prognosis.Disability and mortality rates associated with PSCI increase with age.In clinical practice, conditions such as post-stroke delirium and transient cognitive impairment may resolve early, whereas PSCI diagnosis typically requires cognitive assessment conducted 3-6 months after stroke.Delaying intervention until a definitive PSCI diagnosis is confirmed may result in missing the optimal treatment window.Therefore, thorough understanding of PSCI risk factors, early screening of acute stroke patients, development of prediction models, and early identification of high-risk individuals for specialized management can improve outcomes for PSCI patients.This review summarizes recent progress on PSCI risk factors across three domains: neuropsychological assessment scales, neuroimaging techniques (magnetic resonance imaging, ultrasound, brain networks),and blood biomarkers.Additionally, it evaluates the advantages and limitations of clinical prediction models constructed using key, easily accessible risk factors, aiming to provide insights for early identification and management of high-risk PSCI populations.

  • 3.
    Interpretation and perspectives on the Chinese Consensus on the Diagnosis and Management of Cerebral Amyloid Angiopathy (2023 edition)
    Jun Ni, Bin Peng
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (04): 280-283. DOI: 10.3877/cma.j.issn.1673-9248.2025.04.003
    Abstract (538) HTML (14) PDF (1597 KB) (107)

    Cerebral amyloid angiopathy (CAA) is an age-related cerebral small vessel disease characterized by the deposition of β-amyloid in the walls of small arteries, arterioles, and capillaries within the leptomeninges, cortex, and cerebellum. It is the leading cause of spontaneous lobar intracerebral hemorrhage in the elderly and a major etiological factor in age-related cognitive decline. The current diagnostic standard, the Boston criteria, integrates pathological, clinical, and neuroimaging features and is widely used in both clinical and research settings. However, awareness of CAA remains suboptimal in China, and existing diagnostic criteria do not fully align with the needs of routine clinical practice. Additionally, there has been a lack of nationwide guidelines or expert consensus on the diagnosis, prevention, and treatment of CAA in China. To bridge this gap, the Chinese Society of Neurology and its Cerebrovascular Disease Study Group convened a panel of experts to develop the Chinese Consensus on the Diagnosis and Management of Cerebral Amyloid Angiopathy (2023 edition) (hereinafter referred to as the Consensus). Adhering to internationally recognized methodological standards, the Consensus systematically reviewed the latest global evidence and provided evidence-based recommendations addressing 14 key clinical issues in CAA diagnosis and management. These recommendations aim to standardize clinical practice and serve as a practical guide for Chinese neurologists. This article delves into the Consensus's core recommendations to enhance their comprehension and clinical implementation.

  • 4.
    Effects of cognitive-motor dual-task training on post-stroke cognitive impairment
    Runyi Du, Yumei Zhang, Lipeng Liu, Weijun Gong
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 87-93. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.002
    Abstract (373) HTML (31) PDF (2466 KB) (62)

    Objective

    To investigate the effects of cognitive-motor dual-task training (DTT)on multidimensional cognitive function and activities of daily living (ADL) in patients with post-stroke cognitive impairment (PSCI).

    Methods

    A total of 28 eligible patients with PSCI admitted to the Department of Rehabilitation Medicine at Beijing Tiantan Hospital, Capital Medical University, from August 2023 to September 2024 were enrolled and randomly assigned to a control group (n=14) and an intervention group (n=14).The control group received cognitive training alone (5 sessions/week, 30 minutes/session, for 2 weeks),while the intervention group underwent cognitive-motor DTT with identical training frequency and duration.Pre- and post-training scores on the Stroop color-word test (SCWT), Rey-Osterrieth complex figure test (ROCF),digit symbol substitution test (DSST), and Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog)were compared between groups.Additionally, differences in Montreal cognitive assessment (MoCA),modified Barthel index (MBI), and functional independence measure (FIM) scores at 1-month follow-up were analyzed relative to baseline.

    Results

    Compared with the control group, the intervention group showed significantly higher scores in DSST (P<0.05), MBI (P<0.05), and FIM (P<0.05), and lower ADAS-Cog scores (P<0.05) at 1-month follow-up.Both groups exhibited improved ROCF and MoCA scores after training, without statistical significance.SCWT completion time decreased post-training, without statistical significance (P>0.05).

    Conclusion

    Cognitive-motor DTT may cognitive functions related to attention and memory, as well as improve ADL capabilities in PSCI patients.Further research is needed to validate its long-term efficacy.

  • 5.
    Advances in probes and technologies for detecting cerebral ischemia-reperfusion injury
    Qidan Pang, Wei Cui, Tao Tang, Dechun Jiang, Shen Li
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 149-154. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.010
    Abstract (368) HTML (11) PDF (2673 KB) (15)

    Ischemic stroke is a major global health challenge with profound impacts on human well-being.Reperfusion therapy represents the most effective intervention, yet successful blood flow restoration often triggers cerebral ischemia-reperfusion injury (CIRI), a complex pathological cascade that exacerbates structural damage and functional deficits.Real-time monitoring, early warning, and timely intervention are prerequisites for mitigating CIRI.Consequently, the development of highly sensitive and specific probes and technologies for CIRI detection has emerged as a research priority.This review systematically summarizes advances in molecular probes and analytical platforms targeting CIRI-related reactive species, mitochondrial dysfunction, and biothiol homeostasis.These innovations not only provide diagnostic and therapeutic insights for CIRI but also serve as critical tools for advancing neuroprotective strategies.

  • 6.
    Assessment and diagnosis of vascular cognitive impairment
    Xiaoling Liao
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 166-166. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.013
    Abstract (335) HTML (0) PDF (2493 KB) (1)

    【视频简介】血管性认知障碍(vascular cognitive impairment,VCI)是指主要由脑血管病及其危险因素导致的认知功能障碍,包括从轻度认知障碍(mild cognitive impairment,MCI)到痴呆的整个过程,可以与阿尔茨海默病(Alzheimer's disease,AD)等神经退行性疾病共病。我国60 岁及以上人群痴呆患病率为6.0%,其中血管性痴呆(vascular dementia,VaD)为1.6%,是仅次于AD 的常见痴呆类型;我国65 岁及以上人群中MCI 患病率为20.8%,其中VCI 可占MCI 总体的42%。

    VCI 临床表现多样,认知障碍表现与脑血管病表现并存,执行功能障碍相对比较突出,严重时可显著影响患者日常生活及工作。VCI 发病率高,危害大,但又是相对可预防可治疗的,因此,早期正确评估、诊断与防治有助于降低其发病或风险,改善患者预后。VCI 患者可能会在神经科、老年科、全科医学、精神科、康复科等多个科室就诊,统一VCI 的定义及分型,建立规范的VCI 评估与诊疗路径,有利于促进适合国人的VCI 精准诊断与防治体系的建立,提高我国VCI 防治水平,降低疾病负担。

  • 7.
    Application of CT cerebral perfusion in disease severity assessment and surgical planning for patients with large-area cerebral infarction
    Jianlong Su, Wenjian Zhen, Yuting Sun, Jinmin Hao
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 133-140. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.008
    Abstract (330) HTML (2) PDF (4550 KB) (14)

    Objective

    To explore the application value of CT cerebral perfusion imaging in assessing disease severity and guiding surgical planning for patients with large-area cerebral infarction.

    Methods

    A retrospective analysis was conducted on 126 patients with large-area cerebral infarction admitted to Xingtai Central Hospital from September 2021 to September 2023.All patients underwent CT cerebral perfusion imaging, and disease severity was evaluated using the National Institutes of Health stroke scale(NIHSS).Based on NIHSS scores, patients were categorized into mild (NIHSS score ≤ 4, 0 cases), moderate(NIHSS 5-20, 92 cases), and severe (NIHSS>20, 34 cases) groups.CT perfusion imaging was analyzed for detecting infarct location and size, comparing cerebral perfusion parameters across different brain regions,assessing correlations between perfusion parameters and disease severity, and informing surgical decision-making.

    Results

    Among 126 patients, infarct locations included the basal ganglia (34.13%, 43 cases), frontal lobe(29.37%, 37 cases), temporal lobe (25.40%, 32 cases), occipital lobe (17.46%, 22 cases), and parietal lobe(4.76%, 6 cases).Infarct volumes were categorized as 10-15 cm3 (42.06%, 53 cases), >15-25 cm3 (37.30%,47 cases), and >25 cm3 (20.64%, 26 cases).Compared to healthy contralateral regions, both the infarct core and ischemic penumbra showed significantly lower cerebral blood flow (CBF) and cerebral blood volume(CBV), and higher time-to-peak (Tmax) and mean transit time (MTT) (all P<0.05).The severe group exhibited lower CBF and CBV and higher Tmax and MTT in the infarct core than the moderate group (P<0.05).Spearman correlation analysis revealed negative associations between CBF/CBV and disease severity(r=-0.419, P<0.05; r=-0.522, P<0.05) and positive association between Tmax/MTT and disease severity(r=0.356, P<0.05; r=0.617, P<0.05).Logistic regression identified CBF, CBV, Tmax, MTT, and infarct volume as independent predictors of disease severity (P<0.05).Receiver operating characteristic curves demonstrated areas under the curve of 0.820 (CBF), 0.755 (CBV), 0.766 (Tmax), 0.842 (MTT), and 0.610(infarct volume) for severity assessment.All patients received medical treatment, with 94 undergoing arterial thrombolysis and 32 decompressive craniectomy.Postoperative survival was 94.44% (119/126), with 7 deaths and residual neurological sequelae in some survivors.

    Conclusion

    CT cerebral perfusion effectively identifies infarct location and vomule, evaluates disease severity, and provides critical insights for surgical planning in patients with large-area cerebral infarction.

  • 8.
    Research advances in cerebral small vessel disease and its associated cognitive impairment
    Yu Xia, Han Liu, Rui Zhu
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 155-160. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.011
    Abstract (327) HTML (11) PDF (2447 KB) (42)

    In recent years, the rapid advancement of neuroimaging techniques and the continuous discovery, validation and exploration of novel biomarkers have significantly increased the detection rate of cerebral small vessel disease (CSVD).Cognitive impairment caused by CSVD is highly prevalent and exerts a substantial negative impact on the quality of life among the Chinese population.Consequently, CSVD and its associated cognitive impairment have emerged as both a major focus and a substantial challenge in scientific research.Current evidence strongly supports that inflammatory mechanisms, particularly vascular inflammatory responses mediated by lipoprotein-associated phospholipase A2 (LP-PLA2), play a critical role in the pathogenesis and progression of CSVD and its cognitive sequelae.For instance, LP-PLA2-driven pathways may contribute to blood-brain barrier disruption, structural and functional damage to vascular endothelium, acceleration of atherosclerosis, and sustained chronic inflammatory states, all of which collectively influence the initiation and progression of CSVD-related cognitive impairment.This review aims to synthesize recent advances in understanding cognitive impairment in CSVD and to elucidate the biological role of LPPLA2 as a representative mediator of specific vascular inflammatory responses in its pathological cascade.

  • 9.
    Evolution of temporal interference stimulation: from technical principles to clinical applications
    Liang Huang, Binxiang Xu, Kai Wang, Long Li, Lin He, Qiang Gao, Jun Zhao, Tian Liu
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (05): 353-363. DOI: 10.3877/cma.j.issn.1673-9248.2025.05.001
    Abstract (288) HTML (37) PDF (3894 KB) (129)

    Temporal interference (TI) stimulation is a novel non-invasive neuromodulation technology. It generates low-frequency envelopes through the interference effect of two high-frequency alternating currents, enabling precise targeting of deep brain regions. This approach overcomes a major limitation of conventional non-invasive neuromodulation techniques, which are often ineffective in stimulating deeper brain structures. In recent years, research on TI stimulation has progressed rapidly and has become a hotspot in the field of neuromodulation. It demonstrates promising clinical potential for treating neurological disorders and may offer a non-invasive alternative for conditions involving dysfunction in deep brain circuits. This paper systematically reviews the research progress related to TI stimulation in recent years. Beginning with the principles of TI stimulation technology, it elaborates on its progress in simulation optimization and hardware development, and deeply explores its potential for the treatment of neurological diseases by incorporating clinical application cases, providing a reference for the further research and application of this technology.

  • 10.
    Reseach progress of cerebral small vessel disease
    Bin Peng
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (04): 352-352. DOI: 10.3877/cma.j.issn.1673-9248.2025.04.014
    Abstract (278) HTML (0) PDF (511 KB) (0)

    脑小血管病通常指发生于脑小动脉、微动脉、毛细血管、微静脉和小静脉的病变,主要分为小动脉硬化型(年龄和血管危险因素相关型小血管病)散发性或遗传性脑淀粉样血管病及其他遗传性脑小血管病炎性或免疫介导性小血管病静脉胶原化小血管病及其他病因所致的脑小血管病。影像学技术的发展极大地推动了脑小血管病的研究。从2013年的STRIVE v1标准到2023年的STRIVE v2标准,对脑小血管病的影像学标志物有了更明确的定义,也提出了新的以及潜在的影像学标志物,影像技术的进展将进一步推进脑小血管病的研究。脑小血管病的临床表现多样,如急性缺血性腔隙性梗死、脑出血可导致急性神经功能障碍,但更多脑小血管病呈慢性进展表现,如认知功能障碍、步态障碍、二便功能障碍及情感障碍等。脑小血管病发病机制及临床表现的多样性决定了其治疗及预防措施具有与大血管病不同的特点,尤其在脑小血管病的抗栓治疗上值得进一步研究,需要对脑小血管病抗栓治疗的必要性、有效性、安全性等方面进行综合评估。本视频对近年来脑小血管病的相关研究进展进行总结,结合本课题组的有关研究来探讨脑小血管病的评估、诊断、治疗及预防策略,供大家参考。

  • 11.
    Association between asymptomatic posterior cerebral artery therosclerotic stenosis and cognitive function
    Anqi Cheng, Yinxi Zou, Qianqian Si, Xiaoyuan Fan, Xiaoqian Zhang, Mingli Li, Feng Feng, Caiyan Liu, Weihai Xu
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 94-99. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.003
    Abstract (242) HTML (13) PDF (2372 KB) (38)

    Objective

    To explore the characteristics of global cognitive function and domain-specific cognitive test performance in patients with asymptomatic posterior cerebral artery atherosclerotic stenosis (aPCAS).

    Methods

    A total of 19 patients diagnosed with aPCAS (stenosis >50%) at the Neurology Department of Peking Union Medical College Hospital between February 2021 and July 2024 were enrolled, along with 53 age-, sex-, and education-matched control subjects.Linear regression models were used to compare Z-scores across cognitive domains (including memory, attention, executive function, visuospatial ability, language, and calculation) and cognitive test results [including the mini-mental state examination (MMSE), Montreal cognitive assessment(MoCA), and domain-specific subtests] between the two groups, with demographic variables statistically adjusted.P-values were corrected using the Bonferroni method.

    Results

    Compared to the control group, the aPCAS group exhibited significantly lower MoCA scores [(23.11±4.25) vs(26.47±3.03), β=-3.46, 95% CI: -4.88 to -2.03, P<0.001], as well as reduced Z-scores in the memory[(-0.94±0.73) vs (-0.27±0.73), β=-0.67, 95% CI:-1.07 to -0.28, P=0.001], language [(-0.09±0.88) vs(0.83±0.85), β=-0.91, 95% CI: -1.37 to -0.46, P<0.001], and calculation [(-0.82±0.91) vs (0.02±0.92),β=-0.84, 95% CI: -1.34 to -0.33, P=0.001].

    Conclusion

    Despite the absence of stroke episodes,aPCAS patients demonstrate cognitive impairment even with mild cortical atrophy and low white matter hyperintensity burden, indicating that they should be considered a high-risk population for dementia.

  • 12.
    Effect of traditional Chinese medicine hot compress therapy on limb function and serum neurotrophic factor levels in ischemic stroke patients with hemiplegia
    Yanzhen Xiong, Yuejuan Zhang, Xiaoqian Wang, Qiuyu Zhou, Caihong Zhuo
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (04): 318-323. DOI: 10.3877/cma.j.issn.1673-9248.2025.04.009
    Abstract (211) HTML (2) PDF (2254 KB) (9)
    Objective

    To evaluate the clinical effects of traditional Chinese medicine (TCM) hot compress therapy on limb function and its impact on serum levels of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) in ischemic stroke (IS) patients with hemiplegia.

    Methods

    A total of 122 IS patients with hemiplegia treated at the Acupuncture, Moxibustion, and Rehabilitation Center of the First Affiliated Hospital of Hunan University of Chinese Medicine from May 2022 to May 2024 were enrolled. Patients were divided into an observation group (n=61) and a control group (n=61) based on different treatment protocols. Both groups received routine therapy. The control group underwent Bobath-based limb rehabilitation training, while the observation group received additional TCM hot compress therapy. Treatment duration was 4 weeks for both groups. The χ2 test was used to compare clinical efficacy rates, and independent t-tests were applied to assess differences in National Institutes of Health stroke scale (NIHSS) scores, Fugl-Meyer assessment (FMA) scores, and serum NGF/BDNF levels.

    Results

    After treatment, the observation group demonstrated a significantly higher total efficacy rate (83.61% vs 65.57%, χ2=4.425, P=0.038). Post-treatment NIHSS scores decreased markedly in both groups, with lower scores in the observation group (7.39±0.91 vs 9.72±1.47, t=10.526, P<0.001). Both upper and lower limb FMA scores increased substantially, showing superior improvement in the observation group (upper limb: 39.11±5.41 vs 34.01±4.97; lower limb: 25.12±4.04 vs 20.56±3.61; t=5.442, 6.574, all P<0.001). Serum NGF and BDNF levels were significantly elevated in the observation group [NGF: (9.46±1.36) ng/mL vs (8.27±0.97) ng/mL; BDNF: (5.62±0.73) ng/mL vs (4.41±0.59) ng/mL; t=5.564, 10.068, all P<0.001].

    Conclusion

    TCM hot compress therapy demonstrates definite efficacy in improving limb function in IS patients with hemiplegia. It effectively enhances motor recovery, reduces neurological impairment, and may exert these benefits through upregulation of serum NGF and BDNF levels.

  • 13.
    Advances in diagnosis and treatment of antiphospholipid syndrome-related ischemic stroke
    Haiquan Gao, Lixin Zhou, Jun Ni
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (04): 332-339. DOI: 10.3877/cma.j.issn.1673-9248.2025.04.011
    Abstract (211) HTML (16) PDF (2966 KB) (54)

    Antiphospholipid syndrome (APS) is an acquired thrombotic disorder with major clinical implications in ischemic stroke, particularly among young adults and in case of cryptogenic stroke. Antiphospholipid antibodies (aPLs) substantially increase stroke risk through multiple prothrombotic mechanisms, including vascular endothelial dysfunction, platelet activation, and complement system dysregulation. Thrombotic risk stratification requires comprehensive assessment of antibody profiles (e.g., triple positivity or positivity lupus anticoagulant), coexisting systemic lupus erythematosus (SLE), and traditional cardiovascular risk factors. APS-associated ischemic stroke exhibits complex pathophysiology, mediated by hypercoagulability, cardioembolism, large artery atherosclerosis, or small vessel occlusion. However, the absence of specific clinical or imaging biomarkers, complicates early diagnosis. Additionally, APS-related stroke is associated with a high recurrent rate and poor prognosis. Current evidence supports long-term anticoagulation as the cornerstone of secondary prevention, while high-risk patients (e.g., those with triple-positive antibody profiles) may benefit from combined antiplatelet agents or immunosuppressive therapies. This review emphasizes the urgent need to enhance early recognition and diagnosis of APS-related stroke, refine risk stratification for recurrence, and advance mechanistic research to develop precision secondary prevention strategies that address the underlying pathogenesis, ultimately improving clinical outcomes.

  • 14.
    Correlation between retinal thickness and cognitive impairment in cerebral small vessel disease
    Qi Han, Tiansiyu Wen, Yiqin Xiao, Mei Cui
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 109-114. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.005
    Abstract (198) HTML (6) PDF (2365 KB) (18)

    Objective

    To investigate the correlation between retinal thickness and cognitive impairment in patients with cerebral small vessel disease (CSVD).

    Methods

    A total of 161 CSVD patients treated at the Department of Neurology, Huashan Hospital Affiliated to Fudan University from September 2022 to May 2024 were enrolled.Based on the Montreal cognitive assessment (MoCA) scores, patients were divided into a non-cognitive impairment group (29 cases) and a cognitive impairment group (132 cases).Optical coherence tomography (OCT) was used to measure retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC) thickness in the optic disc and macular regions.Retinal parameters were compared between the two groups, followed by univariate and multivariate logistic regression analyses.Spearman correlation analysis was used to explore the associations between independent influencing factors and MoCA scores.

    Results

    The temporal RNFL thickness of the optic disc in the cognitive impairment group [75.0 (68.0,81.5) µm] was significantly thinner than that in the non-cognitive impairment group [86.0 (72.5, 92.0) µm],with a statistically significant difference (Z=2.602, P=0.009).Logistic regression analysis revealed that thicker temporal RNFL of the optic disc was an independent protective factor against cognitive impairment in CSVD patients (OR=0.96, 95% CI: 0.92-0.99, P=0.032).Temporal RNFL thickness was positively correlated with MoCA scores (r=0.235, P=0.006).

    Conclusion

    Thicker temporal RNFL of the optic disc is an independent protective factor against cognitive impairment in CSVD patients.

  • 15.
    Mechanism and research progress of lactic acid and lactylation in ischemic stroke
    Hongmei Qiao, Jingfen Zhang, Baojun Wang
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (04): 274-279. DOI: 10.3877/cma.j.issn.1673-9248.2025.04.002
    Abstract (198) HTML (12) PDF (2217 KB) (36)

    Lactate serves not only an important energy metabolite in the nervous system but also participates in the regulation of cellular functions. Under conditions of hypoxia or increased neuronal activity, astrocytes generate lactate through glycolysis, providing energy support to neurons via the lactate shuttle mechanism. Stroke-induced ischemia and hypoxia significantly elevate lactate levels. Lactate not only contributes to energy metabolism but also influences lactylation modifications and functions as a signaling molecule in cellular regulation. This article reviews the alterations in lactate metabolism and lactylation during ischemic stroke and their impacts on neuroprotection and recovery, offering new insights and strategies for clinical treatment of stroke.

  • 16.
    Interpretation of the “Chinese Stroke Association Guidelines on Reperfusion Therapy for Acute Ischemic Stroke 2024”
    Zhongling Zhang
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (06): 566-566. DOI: 10.3877/cma.j.issn.1673-9248.2025.06.018
    Abstract (181) HTML (0) PDF (673 KB) (0)

    脑卒中严重威胁人类健康,缺血性卒中已经占到卒中患者的80%以上。急性缺血性卒中(‌acute ischemic stroke,AIS)超早期再灌注治疗已经成为一线治疗手段,使无数患者摆脱死亡和残疾,回归家庭和社会,再灌注治疗包括静脉溶栓和机械取栓。近年来,随着诸多高质量随机对照试验(randomized control trial,RCT)研究结果的发布,再灌注治疗的指南得到及时更新,给临床医师提供了最新的治疗理念和方案,以期使更多患者获益。

    静脉溶栓药物由既往单一的阿替普酶扩展到了4种。发病4.5 h内,美国国立卫生研究院卒中量表(National Institute of Health stroke scale,NIHSS)评分≥4分的AIS,均可应用替奈普酶或阿替普酶进行静脉溶栓治疗(Ⅰ类推荐,A级证据),瑞替普酶或重组人尿激酶原(recombinant human prourokinase,rhPro-UK)也可选择应用(Ⅱa类推荐,B级证据)。同时,对于时间窗的拓展、醒后卒中、轻型致残性卒中等方面的溶栓治疗亦给予最新推荐,但是也强调了使用多模式影像对缺血半暗带的必要筛选,时间窗向组织窗的转化使越来越多的患者得到再灌注治疗。对于NIHSS评分≥6分、前循环大血管闭塞(large vessel occlusion,LVO)且灌注成像提示梗死核心/低灌注不匹配,但无法进行机械取栓的AIS患者,发病时间4.5~24.0 h内,推荐使用替奈普酶0.25 mg/kg进行静脉溶栓治疗(Ⅰ类推荐,A级证据)。

    AIS机械取栓绿色通道流程的制定,使临床路径更加清晰,缩短再通时间,促进血管内治疗的高效开展,在多模式影像指导下,前、后循环的大血管闭塞24 h内均可进行取栓治疗;同时强调了先溶栓后取栓(即桥接治疗)仍是主流方案,对于桥接前的溶栓药物选择也给出了相应推荐。新指南的发布必将为临床医师规范AIS再灌注治疗指明方向!

  • 17.
    Clinical efficacy of 3D printing technology-assisted neuroendoscopic treatment for supratentorial hypertensive cerebral hemorrhage with vertricular extension
    Jinhong Qian, Jiandong Wu, Xiaoyu Tang, Peng Deng, Zhiliang Ding, Mian Ma
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 126-132. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.007
    Abstract (177) HTML (1) PDF (13610 KB) (17)

    Objective

    To investigate the clinical efficacy of 3D printing-assisted neuroendoscopic surgery in treating supratentorial hypertensive intracerebral hemorrhage (HICH) with intraventricular extension.

    Methods

    A retrospective analysis was performed on 50 patients with supratentorial HICH and intraventricular hemorrhage admitted to the Department of Neurosurgery, Suzhou Municipal Hospital from October 2020 to April 2023.Patients were divided into a control group [(25 cases, treated with traditional microscopic surgery + external ventricular drainage (EVD)] and an observation group(25 cases, treated with 3D printing-assisted neuroendoscopic surgery + EVD).Demographic and clinical parameters were compared between groups, including age, sex, hematoma volume, Glasgow coma scale(GCS) score, preoperative muscle strength of the affected limb, operative time, bone window area, EVD duration, hospitalization duration, hematoma clearance rates (intraparenchymal and intraventricular),rebleeding episodes, intracranial/pulmonary infection cases, modified Rankin scale (mRS) scores at 3-month follow-up, and postoperative muscle strength at 3 months in patients with preoperative mild/moderate compression of the posterior limb of the internal capsule.

    Results

    No significant differences were observed between groups in age, sex, hematoma volume, GCS score, or preoperative muscle strength (P>0.05).The observation group showed significantly shorter operative time, smaller bone window area, shorter EVD duration, and reduced hospitalization time compared to the control group(P<0.05).While intraparenchymal hematoma clearance rates were comparable (P>0.05), the observation group achieved significantly higher intraventricular hematoma clearance rates (P<0.05).Rates of rebleeding,intracranial infection, and pulmonary infection were lower in the observation group, though without statistical significance (P>0.05).No intergroup significant difference was found in 3-month mRS scores (P>0.05); however, patients with preoperative mild/moderate posterior limb compression in the observation group exhibited significantly improved postoperative muscle strength at 3 months (P<0.05).

    Conclusion

    3D printing-assisted neuroendoscopic minimally invasive surgery effectively clears both intraparenchymal and intraventricular hematomas, offering advantages of minimal trauma, shorter operative time, and reduced hospitalization.It represents a promising therapeutic modality for hypertensive intracerebral hemorrhage.

  • 18.
    Analysis of risk factors for early neurological deterioration in patients with branch atheromatous disease after intravenous thrombolysis
    Min Li, Mengfei Zhong, Mengliang Hu, Shasha Ba
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (04): 304-311. DOI: 10.3877/cma.j.issn.1673-9248.2025.04.007
    Abstract (171) HTML (7) PDF (2987 KB) (43)
    Objective

    To investigate risk factors for early neurological deterioration (END) following intravenous thrombolysis in patients with branch atheromatous disease (BAD)-related stroke and to develop and validate a predictive nomogram.

    Methods

    We retrospectively analyzed data from 263 patients with BAD-related stroke who received intravenous thrombolysis at the Department of Neurology, Shengli Oilfield Central Hospital (Dongying, Shandong Province) between January 2016 and December 2024. Patients were divided into END (n=104) and non-END (n=159) groups based on the occurrence of END. LASSO regression was used to identify factors associated with END, which were then used to construct a risk nomogram using the R software.

    Results

    Significant differences were found between the END and non-END groups in terms of responsible vessels distribution, infarct location, fasting blood glucose level on the following day, pre-thrombolysis National Institute of Health stroke scale (NIHSS) score, and the muscle strength score of the pre-thrombolysis NIHSS score (all P<0.05). Multivariate logistic regression identified infarct location in the pons [OR=10.438, 95%CI: 3.286–38.495, variance inflation factor (VIF) value=1.083], fasting blood glucose level on the following day (OR=1.248, 95%CI: 1.072–1.475, VIF value=1.022), and muscle strength score of the pre-thrombolysis NIHSS score (OR=1.201, 95%CI: 1.014–1.429, VIF value=1.067) as independent risk factors for END (P<0.05). The predictive nomogram based on the independent risk factors and internally validated through bootstrapping showed good calibration, and strong predictive performance, with an area under the ROC curve of 0.896 (95%CI: 0.850–0.943).

    Conclusion

    Pontine infarction, elevated next-day fasting blood glucose, and muscle strength score of the pre-thrombolysis NIHSS score are independent risk factors for END after intravenous thrombolysis in patients with BAD-related stroke. The constructed nomogram provides a clinically useful tool for predicting END with high accuracy.

  • 19.
    Advances in research on the association between cerebral small vessel disease and gait and balance dysfunction
    Chenglu Mao, Yun Xu
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (04): 267-273. DOI: 10.3877/cma.j.issn.1673-9248.2025.04.001
    Abstract (169) HTML (43) PDF (2529 KB) (72)

    Cerebral small vessel disease (CSVD) refers to a group of clinical, imaging, and pathological syndromes resulting from various etiologies affecting intracranial small vessels. Gait and balance disturbances, commonly observed in the elderly, represent the second most frequent clinical manifestations of CSVD. An increasing number of studies have investigated the potential mechanisms underlying CSVD-induced gait and balance disturbances. However, no consensus has been reached, and considerable debate persists regarding their relationship. This review summarizes the current findings the association between CSVD and gait and balance disturbances, aiming to enhance understanding and provide a foundation for future investigations.

  • 20.
    Clinical outcomes and influencing factors in patients with perioperative stroke
    Qiang Huang, Ying Cui, Yingying Zhao, Yongbo Zhang
    Chinese Journal of Cerebrovascular Diseases(Electronic Edition) 2025, 19 (02): 115-125. DOI: 10.3877/cma.j.issn.1673-9248.2025.02.006
    Abstract (168) HTML (8) PDF (2464 KB) (20)

    Objective

    To investigate the impact of perioperative stroke on clinical outcomes and identify associated factors.

    Methods

    Clinical data of perioperative stroke patients admitted to Beijing Friendship Hospital, Capital Medical University, from January 1, 2018 to January 1, 2022 were analyzed.Perioperative stroke was defined as hemorrhagic or ischemic stroke events occurring during surgery or within 30 day postoperatively in hospitalized patients.The primary endpoint was 90-day all-cause mortality after perioperative stroke.Intergroup differences in variables were compared using Pearson Chi-Square test or Mann-Whitney U test.Variables with P ≤0.10 in univariate analysis were included in logistic regression to identify influencing factors for the primary endpoint.

    Results

    A total of 186 eligible perioperative stroke patients were included, accounting for 3.35% (186/5,547) of all surgical inpatients during the study period,with 32 patients (17.2%) dying within 90 days of perioperative stroke.The cohort included 74 females (39.8%),with median age of 69 (63, 77) years, median National Institutes of Health stroke scale (NIHSS) score of 5 (2, 11), median hospitalization duration of 18 (11, 28) days, and 16 cases (8.6%) of medical disputes.Logistic regression revealed NIHSS score (OR=1.246; 95%CI: 1.146-1.354; P<0.001), age (OR=1.053;95%CI: 1.002-1.106; P=0.040), heart failure (OR=5.484; 95%CI: 1.714-17.549; P=0.004) and international normalized ratio (INR) ≥1.2 (OR=5.226; 95%CI: 1.694-16.120; P=0.004) were independent risk factors for 90-day mortality.

    Conclusion

    Stroke severity, cardiac function, and coagulation status are crucial factors influencing 90-day mortality risk in perioperative stroke patients, warranting focused clinical management.

京ICP 备07035254号-20
Copyright © Chinese Journal of Cerebrovascular Diseases(Electronic Edition), All Rights Reserved.
Tel: 01082266456, 15611963912, 15611963911 E-mail: zhnxgbzzbysy@163.com
Powered by Beijing Magtech Co. Ltd